The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information. The dashboards provide pricing and utilization information for drugs covered under Medicare Parts B and D, including the total amount the program spent on a covered drug, how many beneficiaries used the drug, the cost per unit and the change in price from the prior year. Today’s update adds new fields, including the Average Sales Price, the number of manufacturers producing the drug, and what the drug is used to treat. This information is now available for all covered Part B and D drugs. The 2016 data show double-digit increases in spending per unit (i.e., price) for 876 Part D drugs and 145 Part B drugs, with 31 drugs increasing by more than 100%. CMS also released updated data on the prescription drugs prescribed by individual physicians and other providers paid under Medicare Part D.

Headline
A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why a recent analysis by the Medicare Payment Advisory Commission…
Blog
Public
Medicare Advantage now covers more than half of eligible Medicare beneficiaries, making its impact on hospitals, health systems and patients impossible to…
Headline
The Food and Drug Administration June 22 announced multiple actions to help accelerate early- and late-stage drug development. The actions are part of a larger…
Headline
The AHA drafted and filed an amicus brief June 17 in the 5th U.S. Circuit Court of Appeals in a case regarding Medicaid financing and provider taxes filed by…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services released a proposed rule June 12 seeking to codify the…
Headline
The Medicare Payment Advisory Commission June 15 released its June report to Congress that estimated the association between Medicare Advantage enrollment and…